A Safe and Efficient Method to Retrieve Mesenchymal Stem Cells from Three-dimensional Fibrin Gels
Overview
Biotechnology
Affiliations
Mesenchymal stem cells (MSCs) display multipotent characteristics that make them ideal for potential therapeutic applications. MSCs are typically cultured as monolayers on tissue culture plastic, but there is increasing evidence suggesting that they may lose their multipotency over time in vitro and eventually cease to retain any resemblance to in vivo resident MSCs. Three-dimensional (3D) culture systems that more closely recapitulate the physiological environment of MSCs and other cell types are increasingly explored for their capacity to support and maintain the cell phenotypes. In much of our own work, we have utilized fibrin, a natural protein-based material that serves as the provisional extracellular matrix during wound healing. Fibrin has proven to be useful in numerous tissue engineering applications and has been used clinically as a hemostatic material. Its rapid self-assembly driven by thrombin-mediated alteration of fibrinogen makes fibrin an attractive 3D substrate, in which cells can adhere, spread, proliferate, and undergo complex morphogenetic programs. However, there is a significant need for simple cost-effective methods to safely retrieve cells encapsulated within fibrin hydrogels to perform additional analyses or use the cells for therapy. Here, we present a safe and efficient protocol for the isolation of MSCs from 3D fibrin gels. The key ingredient of our successful extraction method is nattokinase, a serine protease of the subtilisin family that has a strong fibrinolytic activity. Our data show that MSCs recovered from 3D fibrin gels using nattokinase are not only viable but also retain their proliferative and multilineage potentials. Demonstrated for MSCs, this method can be readily adapted to retrieve any other cell type from 3D fibrin gel constructs for various applications, including expansion, bioassays, and in vivo implantation.
Integrating Vascular Phenotypic and Proteomic Analysis in an Open Microfluidic Platform.
Jung S, Cheong S, Lee Y, Lee J, Lee J, Kwon M ACS Nano. 2024; 18(36):24909-24928.
PMID: 39208278 PMC: 11394367. DOI: 10.1021/acsnano.4c05537.
Di Marzio N, Tognato R, Della Bella E, De Giorgis V, Manfredi M, Cochis A Biomater Biosyst. 2024; 14:100094.
PMID: 38596510 PMC: 11001772. DOI: 10.1016/j.bbiosy.2024.100094.
Lee S, Kim H, Kim B, Chae S, Jung S, Lee J Nat Commun. 2024; 15(1):230.
PMID: 38172108 PMC: 10764361. DOI: 10.1038/s41467-023-44427-0.
Biomechanical stimulation promotes blood vessel growth despite VEGFR-2 inhibition.
Johnson B, Johnson A, Heim M, Buckley M, Mortimer B, Berry J BMC Biol. 2023; 21(1):290.
PMID: 38072992 PMC: 10712065. DOI: 10.1186/s12915-023-01792-y.
Tronolone J, Mathur T, Chaftari C, Sun Y, Jain A Bioeng Transl Med. 2023; 8(6):e10582.
PMID: 38023704 PMC: 10658488. DOI: 10.1002/btm2.10582.